Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIPI6398 PET Study in Healthy Volunteers and Schizophrenia Patients
NCT07626034Phase 2Not yet recruiting
- Sponsor
- Zhongze Therapeutics
- Start
- Aug 2026
- Primary completion
- Oct 2027
01
Overview
A Phase 2 trial of ZZ6398 in schizophrenia, sponsored by Zhongze Therapeutics. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ZZ6398
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT07626034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626034.